Forrester 2014.
| Methods | RCT
Method of randomisation: not described
Blinding of outcome assessors: stated as 'no'
Adverse events: no
Deaths: not mentioned
Dropouts: 5 (3 in treatment group, 2 in control group) ITT: no |
|
| Participants | Country: USA
39 participants (21 in treatment group, 18 in control group)
Not ambulatory at start of study
Mean age: 63 years in experimental group and 60 years in control group Inclusion criteria: first stroke; residual lower extremity hemiparesis involving the ankle (1/5 to 4/5 MRC); capable of generating at least trace muscle activation in PF‐DF; adequate language and neurocognitive function; sit in the chair for 30 to 60 minutes per session of ankle training Exclusion criteria: total plegia (0/5) at paretic ankle; fixed or painful contractures; dementia; orthopaedic, arthritic, or inflammatory condition limiting ankle movement; deep venous thrombosis or pulmonary thromboembolism; vision impairment; severe receptive or global aphasia |
|
| Interventions | 2 arms:
|
|
| Outcomes | Outcomes were recorded at baseline and at discharge. Outcome measures: walking ability (Functional Independence Measure walking), balance (Berg Balance Scale), walking velocity, active range of motion, muscle strength, spatiotemporal gait parameters (step time, step length, step symmetry), motor control variables (angular velocity, co‐ordination) |
|
| Notes | Unclear amount of therapy | |
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Random sequence generation (selection bias) | Unclear risk | Not clearly described; authors only state "blocked randomisation" |
| Allocation concealment (selection bias) | High risk | Not described |
| Blinding of outcome assessment (detection bias) All outcomes | High risk | Authors state "not blinded". |
| Incomplete outcome data (attrition bias) All outcomes | High risk | 5 participants were excluded from analysis after randomisation. |